The Oxford-AstraZeneca vaccine had previously been halted for a while.
KEM Hospital in Mumbai's Parel area, which is a government-run facility, will start off with the human trials of Oxford University's Covishield vaccine on Saturday. This will be a first, in the city and the vaccine will be doled out to 3 people for a start, as mentioned by the KEM Dean. The minimum age for volunteers is set at 18 and these volunteers should be healthy adults with no co-morbidities and they must not have contracted COVID-19 before. There is no upper age limit.
The vaccine has been developed in a collaboration with AstraZeneca and in India, this vaccine will be marketed by Pune-based Serum Institute of India (SII) as 'Covishield'. 3 people (two females and a male) have already been given the Covishield shot (a dosage of 0.5 ml) at PGIMER today, in Chandigarh. These 3 volunteers will be monitored for 28 days.
The KEM Hospital Dean also stated that the hospital has started screening more volunteers for the trials and this medical facility will be administering the shot to100 volunteers soon. Dr. Hemant Deshmukh, mentioned that the vaccine will be injected upon three people and another person will be given a placebo, as a part of the regular testing procedure.
The Oxford-AstraZeneca vaccine had previously been halted for a while after the subject had developed a reported nerve ailment. However, AstraZeneca had later clarified that the symptoms were only limb weakness and loss of sensation and the candidate had then recovered.
1,94,303 confirmed cases in Mumbai; 9,100 deaths
As of today, Maharashtra has 1,300,757 confirmed corona cases, out of which Mumbai has reported 1,94,303 patients. When it comes to recovery, the city has seen 1,56,808 cured victims.